R. Wildburger et al., BASIC FIBROBLAST GROWTH-FACTOR (BFGF) IMMUNOREACTIVITY AS A POSSIBLE LINK BETWEEN HEAD-INJURY AND IMPAIRED BONE-FRACTURE HEALING, Bone and mineral, 27(3), 1994, pp. 183-192
Healing of fractures of long bones or large joints is often accelerate
d in patients with severe traumatic brain injury (TBI). However, in th
ese patients an early fracture healing is accompanied by hypertrophic
callus formation or heterotopic ossifications which might even result
in an ankylosis of the affected joints. It seems that enhanced osteoge
nesis in patients suffering from TBI could be caused by some humoral f
actors, since the sera of these patients strongly promote the growth o
f osteoblast cells in vitro. However, humoral growth promoting factors
which could perhaps induce enhanced osteogenesis are not yet identifi
ed. Hence, the aim of this study was to analyse if basic fibroblast gr
owth factor (bFGF) could be related to the phenomenon of enhanced oste
ogenesis, since bFGF stimulates the growth of osteoblasts in vitro and
could be found both in the brain and the bone tissue. For that purpos
e the values of bFGF immunoreactivity were determined in the sera of p
atients with TBI and bone fractures (n = 8) as well as in the sera of
patients with either TBI alone (n = 10) or bone fractures alone (n = 7
), during a period of three months after injury. Quantification of the
bFGF immunoreactivity was done using the ELISA based on monoclonal an
tibodies raised against the recombinant human bFGF. The bFGF immunorea
ctivity values obtained were also compared with the values determined
in the sera of normal, healthy persons (n = 9). In the group of patien
ts with bone fractures alone only a transient increase of bFGF immunor
eactivity (threefold above the normal values) was observed in the seco
nd week after injury. A similar increase of the values of bFGF immunor
eactivity was also determined in the sera of patients with TBI only, b
ut it lasted longer (from the Ist until the 7th to 8th week after inju
ry). In the case of patients with TBI and bone fractures a specific pa
ttern of post-traumatic dynamic change of the values of serum bFGF imm
unoreactivity was observed. Namely, the increase of bFGF immunoreactiv
ity (up to seven-fold above the normal values) was determined even dur
ing the first week after injury. Afterwards, periods of high values of
bFGF immunoreactivity observed during the 2nd, 4th and the 7-10th wee
ks after injury were interrupted by sudden decreases even to the norma
l values (during the 3rd and the 5-6th week after injury). Thus, post-
traumatic increase of the serum bFGF immunoreactivity was induced both
by bone fractures and TBI, while the unusual pattern of its changes c
ould be related to the phenomenon of enhanced osteogenesis in the pati
ents with brain injury.